Literature DB >> 32566539

An Analysis of the Potential Relationship between Crowe Type and Lower Extremity Morphology in Patients with Developmental Dysplasia of the Hip.

Ömer Naci Ergin1, Serkan Bayram1, Fikret Berkan Anarat1, Mehmet Ekinci1, Lezgin Mert1, Emre Özmen1, İrfan Öztürk1.   

Abstract

PURPOSE: To test whether Crowe type is related to femoral alignment and leg length discrepancy by evaluating the preoperative lengths and coronal alignment of femurs, pelvic parameters and hip morphology of patients who underwent primary hip arthroplasty due to coxarthrosis secondary to developmental dysplasia of the hip (DDH).
MATERIALS AND METHODS: Medical records of patients with coxarthrosis secondary to DDH who were treated with total hip arthroplasty at Department of Orthopaedics and Traumatology, Istanbul University Faculty of Medicine between 2008 and 2017 were reviewed. The mechanical axis of lower limbs was analyzed; pelvic height and femoral and tibial lengths were measured. All femurs were classified according to the Dorr classification.
RESULTS: A total of 97 patients were eligible for analysis and were diagnosed with unilateral DDH (n=51) or bilateral DDH (n=46). In those diagnosed with unilateral DDH, the affected pelvis, femur, and tibia were often shorter than the unaffected side. In those diagnosed with bilateral DDH, femoral and pelvic lengths were unpredictable. In the femoral coronal alignment test, data varied widely but were within normal limits. The difference in the Dorr types of femurs was significant between dysplastic and normal sides of patients with unilateral DDH (P=0.001) but not those with bilateral DDH.
CONCLUSION: Especially in patients with unilateral DDH, pelvic heights and femoral and tibial lengths on the affected side may be shorter compared with unaffected side regardless of the Crowe type. Femoral coronal alignment is unpredictable for both groups. Careful preoperative analyses of femoral coronal alignment and pelvic length are advised.
Copyright © 2020 by Korean Hip Society.

Entities:  

Keywords:  Arthroplasty, replacement, hip; Hip dislocation, congenital; Leg length inequality; Lower extremity

Year:  2020        PMID: 32566539      PMCID: PMC7295615          DOI: 10.5371/hp.2020.32.2.85

Source DB:  PubMed          Journal:  Hip Pelvis        ISSN: 2287-3260


INTRODUCTION

The primary aim of total hip arthroplasty (THA) is to relieve pain and recover a functional range of motion of the hip. Deformities and differences in the length of lower extremities are also corrected in certain patients1). After THA, leg length discrepancy can be a source of patient dissatisfaction even if the pain disappears and a functional hip is achieved. Unequal leg lengths, especially in female patients, is a major cause of dissatisfaction after a THA surgery2). THA has also been reported as a highly successful procedure for functional recovery, leg length correction, and pain reduction in patients with coxarthrosis secondary to developmental dysplasia of the hip (DDH)3). Particular anatomical differences are observed in patients with DDH. Femoral deformities such as increased anteversion, aspheric femoral head, and reduced femoral head-neck offset have been reported in patients with acetabular dysplasia4). Some studies also suggest that the femoral neck can be longer on the affected side in patients with unilateral dysplasia5). We hypothesized that the Crowe type DDH affects femoral alignment, femoral medullary canal, and lower extremity length. Therefore, this study aimed to test this hypothesis by evaluating the preoperative lengths and coronal alignment of femurs and pelvis of patients who underwent primary hip arthroplasty due to coxarthrosis secondary to DDH.

MATERIALS AND METHODS

1. Ethics Statement and Subjects

This retrospective study was conducted by evaluating the records of 211 patients with coxarthrosis secondary to DDH who were treated with THA at Department of Orthopaedics and Traumatology, Istanbul University Faculty of Medicine between 2008 and 2017 after receiving approval from the ethics committee of Istanbul University Faculty of Medicine (No. 2018/412). Inclusion criteria required that patients were ≥18 years and diagnosed with DDH in the absence of other congenital or acquired deformities of the hip joint. Patients with previous hip or knee surgery, coxarthrosis secondary to other causes (e.g., trauma, avascular femoral head necrosis, tumor, septic arthritis, and rheumatologic origin) were excluded from the study. Of these 211 patients, 97 (73 female and 24 male) were eligible: 51 with unilateral DDH and 46 with bilateral DDH. The two subcohorts were analyzed separately. All patients had anterior-posterior (AP) pelvic radiographs and standard full-length weight-bearing lower extremity radiographs. Preoperative full-leg radiographs were obtained with patients in a bipedal stance, with knees at maximal extension, feet in neutral rotation, patellae pointing forward, and using blocks under the shorter extremity to correct the coronal pelvic tilt. Picture archiving and communication system (PACS) (Extreme PACS, Ankara, Turkey) was used for all measurements. Hips were classified according to the Crowe system (Table 1), based on the subluxation of femoral heads from the true acetabulum, and correlated with the magnitude and anatomic deformation pattern of the dysplastic hips6).
Table 1

Description of Crowe Classification

GroupDescription
Group 1Subluxation <50% or proximal dislocation <0.1% of the pelvic height
Group 2Subluxation 50-75% or proximal dislocation of 0.1-0.15% of the pelvic height
Group 3Subluxation 75-100% or proximal dislocation of 0.15-0.20% of the pelvic height
Group 4Subluxation >100% or proximal dislocation >0.25% of the pelvic height
Pelvic heights were measured as the distance between the lines connecting the highest points of the iliac crest to the line across the lower edges of the ischial tuberosities. The femoral length was measured from the uppermost endpoint of the femoral head to the femoral medial condyle. The tibial length was measured from the uppermost endpoint of the proximal tibial joint line to the ankle joint (Fig. 1, 2). The threshold selected for significant difference was 0.5 cm7).
Fig. 1

a, b: pelvic orientation lines, c: the height of the hemipelvis was measured as the distance between the lines connecting the highest points of the iliac crest to the line across the lower edges of the ischial tuberosities, d: ischial height was measured as the distance from the teardrop to the line across the bottom edges of bilateral ischial tuberosity.

Fig. 2

a: femoral length was measured from the uppermost endpoint of the femoral head to the femoral medial condyle, b: tibial length was measured from the uppermost endpoint of the proximal tibial joint line to the ankle joint.

The angle formed between the joint line and either the mechanical or anatomical axis is known as the joint orientation angle. The name of each angle specifies whether it is measured based on a mechanical or an anatomic axis. The angle may be measured medial, lateral, anterior, or posterior to the axis line. The angle may refer to the proximal or distal joint orientation of the femur or tibia. The mechanical axis of the lower limb, mechanical lateral distal femoral angle (mLDFA), anatomic lateral distal femoral angle (aLDFA), mechanical lateral proximal femoral angle (mLPFA), anatomic medial proximal femoral angle (aMPFA), and femoral medial neck shaft angle (MNSA) were analyzed in all patients (Fig. 3).
Fig. 3

a: proximal femoral orientation line, b: rotation center of hip, c: distal femoral orientation line, d: anatomic-medial proximal femoral angle, e: mechanic-Lateral proximal femoral angle, f: neck-shaft angle, g: anatomic-lateral distal femoral angle, h: mechanic-lateral distal femoral angle.

Femurs were qualitatively assessed based on three distinct shape patterns and bone structure of the proximal femur8). Type-A femurs have thick medial and lateral cortices on the AP radiographs and a large posterior cortex on lateral radiographs. Thick diaphyseal cortices cause the funnel-shaped proximal femur. Type-B femurs have bone loss from the medial cortex on AP radiographs and from the posterior cortex on lateral radiographs. Their intramedullary canals are wider than that in type-A femurs. Type-C femurs are those which: (i) have lost nearly all medial and posterior cortices and (ii) are thin and might display a fuzzy appearance on radiographs8). All measurements were taken twice by the two authors (F.B.A and M.E) independently with an interval of one week between measurements to decrease intraobserver (inter- and intraclass correlation coefficients [ICCs]=0.992, 95% confidence interval [CI]=0.987–0.995) and interobserver errors (ICCs=0.994, 95% CI=0.991–0.997).

2. Statistical Analyses

Data analyses were performed using IBM SPSS ver. 22.0 (IBM Corp., Armonk, NY, USA). The normality of distribution was tested using the Shapiro–Wilk test. Pearson correlation analysis was used to evaluate the relationships between variables with normal distribution, and Spearman correlation was used for variables displaying non-normal distributions. The level of significance was set at 5%. For comparison among the affected and non-affected sides groups, the paired t-test was used for variables that showed normal distribution in the descriptive statistical methods (mean, standard deviation, minimum, and maximum) when comparing quantitative data. One-way analysis of variance (ANOVA) was performed to determine differences among the four types of Crowe classification. For comparison between these four groups, Tukey's range test was used among post hoc tests. The chi-squared test was used to evaluate differences in Dorr types.

RESULTS

1. Bilateral Dysplasia of the Hip Group

Twenty-five patients had hips with the same Crowe type and 21 with different Crowe types. The mean pelvic height was 204.7±15.4 mm (range, 164–240 mm), ischial height 47.5±8.2 mm (range, 28–65 mm), femur length was 425.1±32.6 mm (range, 350–477 mm), and tibial length was 345.9±29.5 mm (range, 259–395 mm) in the group with the same Crowe type. The mean pelvic height was 217.3±14.6 mm (range, 200–263 mm), ischial height 40.1±8.0 mm (range, 35–66 mm), femur length was 437.1±25.4 mm (range, 385–492 mm), and tibial length was 351.0±22.6 mm (range, 318–397 mm) in the group with different Crowe types. The relationship between Crowe types and pelvic, ischial, femoral and tibial lengths are summarized in Table 2. Overall, pelvic, ischial, femoral, and tibial heights were not related to the Crowe type in patients with bilateral DDH.
Table 2

The Relationship between Crowe Types and Pelvic, Ischial, Femoral, and Tibial Lengths

Same Crowe type (n=25)Different Crowe types (n=21)
Same lengthDifferent lengthSame lengthDifferent length
Pelvic height (mm)14111110
Ischial height (mm)1312129
Femoral length (mm)718417
Tibial length (mm)1312912
According to the Dorr classification, the 50 hips (25 patients) with bilateral DDH with the same Crowe type on the right side were type-A (n=5), type-B (n=18), and type-C (n=2). Results for the left side were similar: type-A (n=7), type-B (n=16), and type-C (n=3). Therefore, there was no significant difference in Dorr types between the left and right femurs in patients with bilateral DDH (P=0.712). A total of 42 hips (21 patients) with bilateral DDH but different Crowe types demonstrated results similar to those observed in the DDH group with the same Crowe types on each side: type-A (n=6), type-B (n=26), and type-C (n=10). It was determined that the Dorr types of femurs were not correlated with Crowe types of the hip in patients with bilateral DDH (P=0.142).

2. Unilateral Dysplasia of the Hip Group

The mean pelvic height of patients with unilateral DDH was 209±2 mm on the affected side and 214±9 mm on the unaffected side. When compared to the pelvic height of the unaffected side, the pelvic height of the affected side was shorter in 15 patients, longer in 7 patients, and similar in 25. The mean ischial height of patients with unilateral DDH was 52.5±8.0 mm on the affected side and 54.1±9.0 mm on the unaffected side. The ischial height was shorter in the affected side in 9 patients, longer than the unaffected side in 3, and similar in 39. The mean femoral length of patients with unilateral DDH was 435.8±31.0 mm on the affected side and 439.4±29.0 mm on the unaffected side. The femoral length was shorter on the affected side in 19 patients, longer on the affected side in 15, and similar in 17. The mean tibial length of patients with unilateral DDH was 353±28 mm on the affected side and 354±31 mm on the unaffected side. The tibial length was shorter on the affected side in 13 patients, longer on the affected side in 13, and similar in 25. Therefore, the Crowe type was not correlated with eventual lengthening in all heights. According to the Dorr classification of patients with unilateral DDH, 10, 34, and 7 hips on the dysplastic side were type-A, type-B, and type-C, respectively, compared with 28, 21, and 2 type-A, type-B, and type-C hips, respectively on the normal side. The difference in the Dorr types of femurs was significant between dysplastic and normal sides in patients with unilateral DDH (P=0.001).

3. Coronal Alignment for all Dysplasia of the Hip

The mean aLDFA was 80.5±3.9°, mLDFA was 86.1±3.7°, aMPFA was 86.7±13.7°, mLPFA was 87.8±13.4°, and MNSA was 132.4±14.2° for all DDH hips. A coronal alignment analysis according to Crowe types is presented in Table 3. The only differences observed were in aMPFA and mLPFA between patients with Crowe types 2 and 3 (P=0.030–0.028) (Table 4).
Table 3

Coronal Alignment Measurements for all DDH

Crowe 1 (n=77)Crowe 2 (n=20)Crowe 3 (n=18)Crowe 4 (n=28)P-value
Mean±SDMin-MaxMean±SDMin-MaxMean±SDMin-MaxMean±SDMin-Max
aLDFA (°)80.8±368-9181.4±674-9980.1±277-8377.5±371-840.32
mLDFA (°)86.5±375-9586.4±578-10185.3±281-8983.4±279-870.71
aMPFA (°)86.4±965-12693.1±1861-12984.7±1266-10183.2±1664-1200.03*
mLPFA (°)88±1261-13282.4±1253-11693.2±1275-11088.9±1759-1160.02*
MNSA (°)132.4±1381-164132.8±13110-155134.5±8124-150128.2±12100-1600.69

DDH: developmental dysplasia of the hip, SD: standard deviation, Min: minimum, Max: maximum, aLDFA: anatomic lateral distal femoral angle, mLDFA: mechanical lateral distal femoral angle, aMPFA: anatomic medial proximal femoral angle, mLPFA: mechanical lateral proximal femoral angle, MNSA: femoral medial neck shaft angle.

*P<0.05.

Table 4

Coronal Alignment Measurements for Unilateral DDH

Dysplastic hipNon-affected sideP-value
MeanSDMin-MaxMeanSDMin-Max
aLDFA (°)81.343.4876-9181.883.7774-920.381
mLDFA (°)86.583.2681-9588.962.9884-96<0.001*
aMPFA (°)86.148.2170-11484.636.6768-1000.462
mLPFA (°)87.8010.3164-12488.448.3874-1300.761
MNSA (°)130.9414.2398-159129.265.58109-1450.445

DDH: developmental dysplasia of the hip, SD: standard deviation, Min: minimum, Max: maximum, aLDFA: anatomic lateral distal femoral angle, mLDFA: mechanical lateral distal femoral angle, aMPFA: anatomic medial proximal femoral angle, mLPFA: mechanical lateral proximal femoral angle, MNSA: femoral medial neck shaft angle.

*P<0.05.

DISCUSSION

Our initial hypothesis was that the Crowe type of DDH affects femoral alignment, femoral medullary canal, and lower extremity length. Our results indicate that in patients with unilateral DDH, the affected side may be shorter than the unaffected side regardless of the Crowe type. Deformity of the hip caused by developmental dysplasia produces anatomical changes in the proximal femur and pelvis, especially the acetabulum. In patients with bilateral DDH, femoral and pelvic lengths are unpredictable. In the femoral coronal alignment test, the average of all data vary widely, however, were within the normal limits. When femoral length was evaluated in patients with acetabular dysplasia, Metcalfe et al.5) noted that the affected femur was longer in the unilateral DDH group compared with the bilateral group who experienced more variability. Another study, conducted by Tamura et al.9) investigated femoral length in 90 patients with unilateral DDH. In their study, femurs were significantly longer in the DDH group compared with the control group. In that study, Tamura et al.9) measured the femoral length which was defined as the vertical distance from the top of the greater trochanter to the most distal end of the intercondylar notch. The different points for measuring femoral length in this study may lead to differences between the lengths in those treated with unilateral DDH. In our study, the affected femur was also shorter in patients with unilateral DDH compared with the femur on the unaffected side. Kocabiyik et al.10) also found that the affected extremity was shorter in patients with unilateral DDH compared with the extremity on the unaffected side. A study conducted by Rai et al.11) revealed that the tibial length on the affected side in patients with DDH was 1 cm shorter compared with the unaffected side. In our series, the average tibial length on the affected side was also shorter in patients with unilateral DDH. Li et al.12) also found that the unaffected side of the pelvis and ischial heights were higher in 100 patients with unilateral DDH as compared to the affected side. Similar to our series, the pelvis and ischial heights in the unilateral DDH group were shorter on the affected side, whereas data were variable in the bilateral group. In tests of coronal alignment, aLDFA was within the normal range (79–83°) and valgus alignment was observed in 28 (19.5%) of 143 hips, with mean values within normal limits. The varus alignment of twenty (13.9%) hips were above the normal limit. In accordance with other studies, patients in this analysis with Crowe type 4 were found to have an average of 77.5° valgus alignment13). Furthermore, mLDFA values of patients with Crowe type 4 were below the normal range in this series. In a study conducted by Kocabiyik et al.10), postoperative coronal alignment of 25 patients with Crowe type 4 was evaluated preoperatively and 1 year postoperatively. The mean mLDFA values in this study were within normal values (85–90°). In the same study, the mean values for aMPFA and mLPFA were found to be 98° and 74°, respectively. Based on these values, the majority of hips in the series were determined to be coxa valga. In our series, aMPFA and mLPFA averages were determined to be 86° and 87°, respectively, both within the normal ranges (80–89° for aMPFA and 85–95° for mLPFA). Mean values of aMPFA and mLPFA in 28 hips with Crowe type 4 in our series were within the normal range, and mLPFA was detected to be lower than 85° in 39 hips (27.2%). Again, the mean value of aMPFA was ≥89° in 41 hips (28.6%), which is within the normal range. To our knowledge, this is first study that evaluated hip morphology according to the Dorr classification in patients with DDH. In our series, patients with unilateral DDH were found to have significantly fewer Dorr type A femurs on the affected side compared to the healthy side. However, the difference between the hips of patients with bilateral DDH was not significant. Although cementless prostheses are recommended for types A and B according to the Dorr classification, the recommendations for type-C remain controversial. However, some reports demonstrated that there is no difference in the cementless prosthesis survival among the three types1415). There are limited studies evaluating pelvic parameters in patients with DDH. Albiñana et al.16) studied a total of 83 patients with unilateral DDH to evaluate the relationship between the pelvic shape and innominate bone in the AP pelvic view. Statistically significant differences were observed in most cases, and pelvic asymmetry was obvious. In their opinion, changes of the pelvic shape occurred in patients with DDH, possibly due to growth disturbances in the triradiate cartilage. However, they did not follow subjects to adulthood to better understand pelvic asymmetry. Another study, Li et al.13) observed that pelvic asymmetry exists in adult patients with DDH. In addition, the degree of asymmetry is correlated with the degree of hip dysplasia. In our study, we noted that the pelvic and ischial heights were higher in the unaffected hip of unilateral DDH patients. We suggest that pelvic asymmetry in adults with DDH may be due to pelvic deformation over years. Pelvic height should be evaluated to obtain better preoperative planning. This study has some limitations. First, it is a retrospective study and a power analysis was not performed before beginning the study. Secondly, sagittal alignment and postoperative changes were not investigated. However, this is the first study on a large cohort that focused on changes in full-length lower extremity length and coronal alignment on patients with both unilateral and bilateral DDH who have undergone THA. Therefore, this study may be used as a reference for future studies to understand mechanical changes affecting the lower extremities in DDH.

CONCLUSION

This study found that pelvic height and femoral length asymmetry are common and unpredictable in the presence of acetabular dysplasia. Femoral coronal alignment is also unpredictable. Surgeons operating on hips of patients with DDH should be aware of such possible anatomical variations. Especially in unilateral DDH patients, the pelvic height and femoral and tibial lengths on the affected side may be shorter compared with the unaffected side regardless of the Crowe type.
  15 in total

1.  Unexpected long femur in adults with acetabular dysplasia.

Authors:  James E Metcalfe; Paul Banaszkiewicz; Birender Kapoor; James Richardson; Charles Wynn Jones; Jan Kuiper
Journal:  Acta Orthop Belg       Date:  2005-08       Impact factor: 0.500

2.  Influence of the Crowe rating on the outcome of total hip arthroplasty in congenital hip dysplasia.

Authors:  H U Cameron; D J Botsford; Y S Park
Journal:  J Arthroplasty       Date:  1996-08       Impact factor: 4.757

3.  Discrepancy in the length of the tibiae in unilateral congenital dislocation of the hip.

Authors:  N N Rai; P D Siney; P A Fleming; B M Wroblewski
Journal:  J Arthroplasty       Date:  1999-10       Impact factor: 4.757

4.  Radiologic pelvic asymmetry in unilateral late-diagnosed developmental dysplasia of the hip.

Authors:  J Albiñana; J A Morcuende; E Delgado; S L Weinstein
Journal:  J Pediatr Orthop       Date:  1995 Nov-Dec       Impact factor: 2.324

5.  Structural and cellular assessment of bone quality of proximal femur.

Authors:  L D Dorr; M C Faugere; A M Mackel; T A Gruen; B Bognar; H H Malluche
Journal:  Bone       Date:  1993 May-Jun       Impact factor: 4.398

6.  Primary cementless total hip arthroplasty in octogenarians. Two to eleven-year follow-up.

Authors:  K S Keisu; F Orozco; P F Sharkey; W J Hozack; R H Rothman; F X McGuigan
Journal:  J Bone Joint Surg Am       Date:  2001-03       Impact factor: 5.284

7.  Changes in Hip, Knee, and Ankle Coronal Alignments After Total Hip Arthroplasty With Transverse Femoral Shortening Osteotomy for Unilateral Crowe Type IV Developmental Dysplasia of the Hip.

Authors:  Ahmet Kocabiyik; Abdulhamit Misir; Turan B Kizkapan; Kadir I Yildiz; Mehmet A Kaygusuz; Yakup Alpay; Atakan Ezici
Journal:  J Arthroplasty       Date:  2017-06-01       Impact factor: 4.757

8.  Femoral deformity in adults with developmental hip dysplasia.

Authors:  D D Robertson; J R Essinger; S Imura; Y Kuroki; T Sakamaki; T Shimizu; S Tanaka
Journal:  Clin Orthop Relat Res       Date:  1996-06       Impact factor: 4.176

9.  Leg-length inequality in people of working age. The association between mild inequality and low-back pain is questionable.

Authors:  A Soukka; H Alaranta; K Tallroth; M Heliövaara
Journal:  Spine (Phila Pa 1976)       Date:  1991-04       Impact factor: 3.468

10.  The radiological research for pelvis asymmetry of unilateral developmental dysplasia of the hip in adult.

Authors:  Ya-Min Li; Jue-Hong Li; Bin Li; Jia-Xing Wang; Yun-Su Chen
Journal:  Saudi Med J       Date:  2016-12       Impact factor: 1.484

View more
  1 in total

1.  [Measurement and analysis of leg length in adults with unilateral developmental dysplasia of the hip].

Authors:  Zhaohui Song; Minzhi Yang; Renwen Guo; Dong Wu; Zhuo Zhang; Jiying Chen; Xiangpeng Kong; Wei Chai
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.